NasdaqGS - Nasdaq Real Time Price
USD
uniQure N.V. (QURE)
24.83
-0.47
(-1.86%)
At close: 4:00:01 PM EDT
26.56
+1.73
(+6.97%)
After hours: 7:12:25 PM EDT
Trade QURE on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for QURE
What's happening with QURE?
Powered by Yahoo ScoutuniQure faces a concentrated regulatory test around AMT-130, its Huntington’s disease gene therapy. Recent commentary highlights uncertainty over four-year durability data and a reported securities investigation, while the company’s next scheduled event is its November 4, 2026third-quarter earnings report. QURE is down 1.86% in the current regular session.
Powered by Yahoo Scout
- Previous Close
25.30 - Open
25.11 - Bid 18.02 x 200
- Ask 30.29 x 200
- Day's Range
23.56 - 25.20 - 52 Week Range
8.73 - 68.62 - Volume
1,821,654 - Avg. Volume
1,993,165 - Market Cap (intraday)
1.722B - Beta (5Y Monthly) 1.06
- PE Ratio (TTM)
-- - EPS (TTM)
-4.03 - Earnings Date Nov 4, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
60.16 - Motley Fool Rating Bearish
Recent News
View More
Performance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
QURE
3.76%
S&P 500 (^GSPC)
10.73%
1-Year Return
QURE
63.41%
S&P 500 (^GSPC)
11.11%
3-Year Return
QURE
337.15%
S&P 500 (^GSPC)
81.91%
5-Year Return
QURE
18.51%
S&P 500 (^GSPC)
64.59%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 10/29/2026
-
Market Cap
1.75B
-
Enterprise Value
1.01B
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (current)
--
-
Price/Sales (ttm)
84.63
-
Price/Book (mrq)
5.41
-
Enterprise Value/Revenue
53.92
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-15.72%
-
Return on Equity (ttm)
-157.61%
-
Revenue (ttm)
18.67M
-
Net Income Avi to Common (ttm)
-252.21M
-
Diluted EPS (ttm)
-4.03
Balance Sheet and Cash Flow
-
Total Cash (mrq)
810.33M
-
Total Debt/Equity (mrq)
170.40%
-
Levered Free Cash Flow (ttm)
-77.58M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
Mkt Cap
undefined
-
Industry
-
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View More-
Lowering target price to $8.00
UNIQURE NV has an Investment Rating of HOLD; a target price of $8.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of Low.
-
What does Argus have to say about QURE?
UNIQURE NV has an Investment Rating of HOLD; a target price of $9.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.
-
What does Argus have to say about QURE?
UNIQURE NV has an Investment Rating of HOLD; a target price of $9.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Low; and a Value Subrating of High.
-
Lowering target price to $9.00
UNIQURE NV has an Investment Rating of HOLD; a target price of $9.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
